These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15535290)

  • 1. [Pathology of ovarian cancer].
    Kaku T; Ogawa S; Hirakawa T; Ohishi Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():471-5. PubMed ID: 15535290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathology of ovarian cancer].
    Kaku T; Watanabe S; Ohishi Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
    [No Abstract]   [Full Text] [Related]  

  • 3. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytology of ovarian epithelial tumors].
    Otsuki T; Yaegashi N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():503-6. PubMed ID: 15535296
    [No Abstract]   [Full Text] [Related]  

  • 5. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
    Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological diagnosis of ovarian cancer].
    Yamabe H
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():507-10. PubMed ID: 15535297
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endometrioid adenocarcinoma of the uterine cervix associated with mucinous ovarian cystadenocarcinoma].
    Ferchichi L; Rammeh-Rommani S; Ben Hammouda S; Sfar R; Farah F; Ben Jilani S; Zermani R
    Gynecol Obstet Fertil; 2006 May; 34(5):410-2. PubMed ID: 16677843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTF-1 expression in primary ovarian epithelial neoplasia.
    Graham AD; Williams AR; Salter DM
    Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic analysis of ovarian cancer associated with endometriosis.
    Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
    Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology of ovarian lesions: the intraoperative approach.
    Jiménez-Ayala M; Jiménez-Ayala Portillo B
    Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Survival of patients with ovarian cancer in the Ul'ianovsk Region, 1999-2005].
    Antoneeva II
    Vopr Onkol; 2007; 53(4):393-5. PubMed ID: 17969399
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent developments in the pathology of ovarian epithelial tumors of low malignant potential and related neoplasms.
    Michael H; Roth LM; Kotylo PK
    Pathol Annu; 1993; 28 Pt 2():1-22. PubMed ID: 8395042
    [No Abstract]   [Full Text] [Related]  

  • 14. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
    Mutch DG; Prat J
    Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.
    Zhou F; Cao X; Liu M; Wang Y; Tao G
    Clin Lab; 2011; 57(5-6):421-4. PubMed ID: 21755835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Hsieh DS; Loh SH; Chen A; Yao CW; Yen CY
    Mod Pathol; 2006 Mar; 19(3):447-52. PubMed ID: 16439987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
    Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
    Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological diagnosis of endometrial cancer in biopsy specimen].
    Kaku T; Watanabe S; Ohishi Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():362-6. PubMed ID: 23156271
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.